Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural genomics in the biotechnology sector.

S Dry1, S McCarthy, T Harris

  • 1Structural GenomiX Inc, San Diego, California 92121, USA.

Nature Structural Biology
|December 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of periprosthetic femoral fractures on frailty, mobility and outcomes in hip arthroplasty.

Journal of orthopaedic surgery and research·2025
Same author

Supporting the mental health and wellbeing of mothers at risk of repeat care proceedings and preventing care entry: a realist evaluation.

Child protection and practice·2025
Same author

Co-design of a Mobile Stroke Unit pathway highlights uncertainties and trade-offs for viable system-wide implementation in the English and Welsh NHS.

BMC emergency medicine·2025
Same author

<i>'They are targeted as fun and better for you than smoking'</i>: Australian parents' opinions about the normalisation of vaping for children and young people.

Perspectives in public health·2025
Same author

'Out-of-stock': An initiative to impede Dermatology in-patient topical treatment delays.

Irish medical journal·2025
Same author

Hidradenitis Suppurativa.

Annual review of medicine·2025
Same journal

Fingering nucleic acids: the RNA did it.

Nature structural biology·2003
Same journal

Histone H1.2 as a trigger for apoptosis.

Nature structural biology·2003
Same journal

Tom40: more than just a channel.

Nature structural biology·2003
Same journal

Announcing the worldwide Protein Data Bank.

Nature structural biology·2003
Same journal

Small RNAs come of age.

Nature structural biology·2003
Same journal

Recognition and processing of the origin of transfer DNA by conjugative relaxase TrwC.

Nature structural biology·2003
See all related articles

Commercial structural genomics provides pharmaceutical companies with crucial data on protein drug targets and lead compound optimization. This field is shaped by public research, new technologies, and evolving intellectual property laws.

Area of Science:

  • Biotechnology
  • Drug Discovery
  • Structural Genomics

Background:

  • Commercial structural genomics supports pharmaceutical R&D by evaluating protein drug targets.
  • It aids in selecting and refining lead compounds from high-throughput screening and rational drug design.

Purpose of the Study:

  • To outline the role and business models of commercial structural genomics.
  • To identify factors influencing commercial structural genomics efforts.

Main Methods:

  • Analysis of commercial structural genomics business models.
  • Review of public domain activities, technological advancements, and intellectual property trends.

Main Results:

  • Commercial structural genomics provides essential data for drug target validation and lead optimization.

Related Experiment Videos

  • Business models vary and are influenced by external scientific and legal factors.

    • Conclusions:

    • Commercial structural genomics is a dynamic field crucial for pharmaceutical innovation.
    • Its success is contingent upon adaptation to scientific progress and intellectual property landscapes.